Peptide Therapy Marketing · Thymosin Beta-4

Thymosin Beta-4 Patient Lead Generation for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Thymosin Beta-4 patients are often the same recovery-focused audience as TB-500 but searching under the full name. They are serious about tissue repair and are usually dealing with injuries that standard care has not resolved. PeptideLeads delivers these patients to your clinic for $50 per qualified lead. No retainer, we cover all ad spend, and founder Tamerlan Musayev built the system to reach every segment of the recovery peptide audience.

The Market Context

Thymosin Beta-4 search volume overlaps with TB-500 and combined runs between 40,000 and 70,000 monthly in the United States. Audience is predominantly male 30 to 55 dealing with tendon, ligament, or soft tissue issues. Close rates are strong because intent is high.

Why This Works

Thymosin Beta-4 protocols often combine with BPC-157. Stacked revenue per patient reaches $3,000 to $6,000 in the first year. At $50 per lead, economics are strong.

How Our Process Works

We run targeted recovery campaigns. Qualification captures injury type, state, prior treatments, and start timeline. Ad spend covered. $50 per qualified lead.

What Makes Us Different

We understand the recovery audience and run it as a core category.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

If your clinic offers Thymosin Beta-4, let's talk.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

Is Thymosin Beta-4 the same as TB-500?

Related. Marketing overlaps significantly.

What does each lead include?

Full contact info, injury, state, prior treatments, and start timeline.

How many leads per month?

Typically 15 to 40.

Is ad spend covered?

Yes.

Is there a retainer?

No.